CD19 and antiphospholipid syndrome: Although numbers of NGF-producing cells were independent of clinical SLE profiles, CD19+ BDNF-producing B cells were dramatically decreased in patients with an associated anti-phospholipid syndrome (40.2 ± 8.9 vs 80.5 ± 22.05, p=0.03).